TruDiagnostic measures DNA methylation from a finger-prick blood spot and reports biological age across several published algorithms rather than as a single proprietary figure. Its panels commonly include a methylation age estimate, the DunedinPACE pace-of-aging measure, biomarker-informed composites, and an estimate of your immune cell proportions.
That reporting style is the whole character of the product. Most consumer tests in this category give you one number and a friendly explanation. This one gives you several numbers that disagree with each other, names the clocks that produced them, and expects you to understand why they differ. For a reader who wants to interrogate a result that is a real advantage. For a reader who wants a quick answer it is a wall. This review covers cost by panel, what each output can and cannot support, the collection experience, and where a different purchase makes more sense.
The Verdict
Scorecard
| Category | Score | Why |
|---|---|---|
| Methodology | 8/10 | DNA methylation from a blood spot, reported across multiple named clocks rather than one figure |
| Method transparency | 8/10 | Names the clocks it runs, including DunedinPACE, and describes the panel composition |
| Reproducibility handling | 7/10 | Reports immune cell deconvolution, which lets you see when cell composition explains a shift |
| Sample collection | 6/10 | Finger-prick blood spot — more fiddly than a saliva swab, and an insufficient sample means a repeat |
| Turnaround | 6/10 | Roughly 3–6 weeks from posting to a full report |
| Report depth | 9/10 | Extensive output, which is the point and also the main usability complaint |
| Actionability | 5/10 | A pace measure is genuinely better for tracking, but no clock names a specific treatable problem |
| Value at price | 6/10 | Roughly $229–$499 depending on panel and plan, as of 2026 |
Cost and what each panel includes
Panel names and contents change, so treat these as ranges to confirm rather than a fixed catalogue. The structure is consistent: a core methylation age panel, a wider panel adding clocks and cell composition, and lower per-test pricing on a recurring plan.
| What you are buying | Typical 2026 price | What it includes | Who it is aimed at |
|---|---|---|---|
| Entry TruAge panel | Roughly $229–$299 | Core methylation age reporting from a blood spot | A first test to establish a baseline |
| Complete or extended panel | Roughly $399–$499 | Multiple clocks including a pace measure, immune cell deconvolution, and a wider report | Someone who wants to interrogate the result, not just read it |
| Subscription plans | Lower per-test pricing on a recurring cadence | Repeat testing at set intervals under the same methodology | Anyone genuinely tracking change across years |
| Clinician-ordered testing | Varies by practice | The same assays ordered and interpreted through a provider | Someone already working with a clinician on this |
The pricing decision that matters is not entry versus complete panel — it is one test versus a series. Every output on this report is more meaningful as a trend. A single reading tells you where you sit against a reference population, which is interesting and close to unactionable. Two readings a year apart under matched conditions, on the same panel, is the minimum configuration where the product does what it is designed to do. Price the series, not the kit.
Methodology, and where the accuracy limits sit
Methylation is a chemical modification: a methyl group attached to a cytosine base at a CpG site. The pattern across selected sites changes with age regularly enough that a trained model can estimate age from it. TruDiagnostic measures those values and runs several published models over them.
Running more than one model is the design decision that distinguishes this product, and the reason is worth stating precisely. Clocks trained on different targets behave differently. A first-generation clock trained to predict calendar age is accurate at guessing your birthday and correspondingly insensitive to health variation. A biomarker-informed composite responds to metabolic and inflammatory status. A pace measure reports a rate. Presenting one number hides which of those you received; presenting several exposes it.
The limits remain real. Individual-level test–retest variation of a few years is common across methylation clocks, which is roughly the size of a year of serious effort. Principal-component versions of the standard clocks were developed specifically to damp that noise. And no methylation output is comparable across vendors, because platforms, normalization pipelines and reference populations all differ.
What each output actually tells you
| Output | What you see | What it is based on | What it cannot tell you |
|---|---|---|---|
| Methylation age (TruAge) | An estimated biological age in years | A methylation-based model over CpG sites | Comparability with any other vendor’s figure |
| DunedinPACE | A rate, where 1.0 is average aging per calendar year | A published pace-of-aging algorithm | A state — it describes speed, not accumulated damage |
| OMICmAge and related composites | Additional age estimates built with biomarker-informed methods | Methylation mapped onto clinical biomarker proxies | A diagnosis, or a validated clinical reference range |
| Immune cell deconvolution | Estimated proportions of blood cell types | Methylation signatures specific to cell lineages | Whether a shift is transient or persistent from one sample |
| Telomere estimate (where included) | An estimated telomere length | A methylation proxy rather than direct measurement | Reliable individual-level information — this measure is noisy |
| Raw data (where offered) | Your methylation values for export | The underlying array or sequencing output | Interpretation — you would need to analyse it yourself |
The pace measure deserves particular attention, because it answers the question most buyers actually have. People rarely want to know how old their biology looks; they want to know whether what they are doing is working. An age estimate answers that badly, since it must overcome its own baseline noise before a change becomes visible, and a baseline taken during a bad month contaminates everything afterwards. A rate measure describes change directly. If you are running a defined intervention and can only follow one line on the report, follow that one.
The telomere estimate deserves the opposite treatment. Telomere length varies substantially between cell types and between draws taken days apart, and published measurement error on consumer assays can exceed the difference between a 40-year-old and a 55-year-old. Read it as context, not as a tracking metric.
How TruHealth Estimates Blood Markers From Methylation
TruHealth is a separate panel that reports around 100 biomarkers across 19 body systems, and it derives all of them from the same methylation data rather than measuring any of them directly. The list reads like a very wide blood panel: CRP, HbA1c, LDL cholesterol, omega-3 index, cortisol, vitamin D, IGF-1, even PFAS exposure. Each of those figures is a model's estimate of what a blood assay would have returned, produced from your methylation signature.
That distinction changes how much weight any single line deserves. A methylation-derived CRP inherits two sources of error stacked on top of each other: the measurement noise in the methylation read itself, and the prediction error of the model converting that read into a CRP value. A direct hs-CRP assay carries only the first kind and costs a few dollars as an add-on to an ordinary blood draw. Where a marker is cheap and widely available, the proxy is the harder number to trust.
The case for the panel sits elsewhere. Estimating 100 markers from one finger prick is genuinely useful for breadth, because it surfaces systems you would not have thought to order, and it produces them all on a single comparable scale from a single sample. Read TruHealth as a wide, low-resolution survey that suggests where to look. Then confirm anything it flags with the direct assay for that marker, particularly for the routine ones your physician can order inexpensively. TruDiagnostic publishes a sample TruHealth report, which is worth reading before purchase to see how the estimates are presented.
Our guide to normal versus optimal ranges covers reading the directly measured versions of these markers, and hs-CRP covers the inflammation marker most often flagged by a wide panel like this one.
Collection experience and turnaround
- Kit arrives with a lancet, a collection card, instructions, and a return mailer.
- Blood spot collection. Warm your hands first and use the side of the fingertip rather than the pad. Fill each circle completely — insufficient volume is the most common reason a sample is rejected, and a rejection means repeating the collection and the wait.
- Drying and registration. Let the card dry as instructed, register the kit identifier, and post it promptly.
- Results. Roughly three to six weeks later, delivered as an online report.
Timing rules matter more than technique. Do not collect within two to four weeks of an illness, a vaccination, an unusually hard training block, or a stretch of badly disrupted sleep — each moves inflammatory markers or cell proportions. Match conditions between samples: same time of day, same fasting state, same season of life. And take two baselines four to six weeks apart before starting an intervention, then average them.
Who it fits, and who should buy something else
| Your situation | Verdict | Reasoning |
|---|---|---|
| You want a pace-of-aging measure to track an intervention | Good fit | DunedinPACE reports a rate, which is less dependent on an unlucky baseline than an age figure |
| You want to know which published clocks produced your result | Good fit | The clocks are named rather than described as proprietary |
| You want to see whether cell composition explains a change | Good fit | Immune cell deconvolution is reported alongside the age outputs |
| You are working with a clinician on this | Good fit | The company supports clinician-ordered testing and research collaboration |
| You want one simple number and no technical detail | Poor fit | The report is dense, and the volume is a common usability complaint |
| You dislike finger-prick blood collection | Poor fit | A blood spot is required, and an insufficient sample means repeating the collection |
| You have never run a comprehensive blood panel | Poor fit | That panel costs less and names specific treatable problems |
| You will test only once | Poor fit | Every output here is more meaningful as a trend than as a single reading |
Trade-offs to weigh
- Depth versus usability. Several disagreeing numbers is more truthful than one confident number, and considerably harder to act on. Readers who wanted a quick answer often find the report overwhelming.
- Blood spot versus swab. A blood spot supports a wider set of measurements and is the more failure-prone collection method.
- Transparency without validation. Naming the clocks lets you look up their published performance. It does not make any of them precise at the individual level.
- Vendor lock-in. Because cross-vendor comparison is invalid, choosing a provider commits you for the length of your tracking horizon.
- Still a surrogate. No output here names a treatable problem. Moving a clock reading has not been shown to cause better outcomes; the clock stands in for health rather than defining it.
How it compares to the direct alternatives
Listed alphabetically. For the wider field scored on a single rubric, see how the five main providers compare across methodologies.
| Option | Method | Typical cost | Primary output | Fits someone who |
|---|---|---|---|---|
| Elysium | DNA methylation from an at-home sample | Roughly $200–$500 depending on plan | A single biological age figure in plain language | Wants one readable number without technical detail |
| Standard blood panel through a clinician | Routine chemistry, lipids, HbA1c, fasting insulin, hs-CRP | $0–$300, frequently insurance-covered when indicated | Specific, treatable findings | Wants information that changes what a doctor does next |
| TruDiagnostic | DNA methylation from a blood spot, multiple named clocks | Roughly $229–$499 depending on panel and plan | Several clock outputs, a pace measure, and cell deconvolution | Wants to interrogate the result rather than read a summary |
Against Elysium, the chemistry is the same family and the philosophy is opposite. Elysium reports one figure in plain language and does not identify the underlying clock. TruDiagnostic reports several named clocks plus cell composition and expects the reader to handle the complexity. Neither approach is more accurate; they make different bets about what a buyer will do with the result. If you would use the extra detail, take it. If you would not, the extra detail is a cost rather than a feature.
Against a standard blood panel, the comparison runs the same way it does for the whole category. A panel covering fasting insulin, HbA1c, ApoB, hs-CRP, liver enzymes and lipids frequently costs less, is often insurance-covered when clinically indicated, and produces findings a physician can act on immediately. Run that first. A methylation panel is a reasonable addition once you already know your treatable numbers, and a poor substitute for them.
Related
- Elysium Index review
- What is biological age — and why tests disagree
- How to lower biological age
- Biological age hub
- Normal vs optimal ranges
Frequently Asked Questions
What is TruDiagnostic and what does it measure?
TruDiagnostic runs DNA methylation testing from a finger-prick blood spot and reports biological age across several published algorithms rather than as one proprietary figure. Its panels commonly include a methylation age estimate, the DunedinPACE pace-of-aging measure, biomarker-informed composites such as OMICmAge, and immune cell deconvolution. The company also works with clinicians and research groups, which is why its reporting is more technical than most consumer products. It is a wellness product and is not regulated as a diagnostic device.
How much does TruDiagnostic cost?
As of 2026 panels typically run in the region of $229 to $499 depending on how much is included, with subscription plans lowering the per-test price for anyone testing on a recurring cadence. Clinician-ordered testing is priced through the practice rather than directly. Confirm current pricing on the company site, since it changes with promotions and panel structure. As with every product in this category, budget on a multi-year basis: a single reading with no comparison point tells an individual very little.
What is DunedinPACE and why does it matter?
DunedinPACE is a published algorithm that estimates the rate at which you are aging, expressed as a speed where 1.0 is the population average — 1.1 means roughly ten percent faster than average. That is a different question from the one an age clock answers. An age clock estimates a state and has to overcome its own baseline noise before a change becomes visible. A pace measure describes change directly and is less dependent on whether your first sample happened to be taken during a bad month. For anyone tracking an intervention, that distinction is the most practically useful thing on the report.
How reproducible are the results?
Better handled here than in most consumer products, and still constrained by the category. Individual-level test–retest variation on methylation clocks is commonly on the order of a few years, which is roughly the size of the change a year of serious effort might produce. Principal-component versions of the standard clocks were developed specifically to reduce that noise. Reporting immune cell deconvolution helps, because it lets you see when a shift in blood cell proportions explains an apparent change. None of that makes a single reading conclusive — two baselines four to six weeks apart, averaged, remains the sound approach.
Why does the report give me several different ages?
Because the clocks were trained on different targets and answer different questions, and showing only one would hide that. A first-generation clock trained to predict calendar age is designed to be insensitive to health variation. A biomarker-informed composite responds to metabolic and inflammatory status. A pace measure reports a rate rather than a state. Seeing them side by side is more informative than a single figure, and it explains why a number from any other vendor will not match. It is also the main reason readers find the report overwhelming.
What is the collection process like?
A finger-prick blood spot, collected at home and posted back, with results typically arriving three to six weeks later. This is more fiddly than a saliva swab, and an insufficient sample volume means repeating the collection and waiting again — warming your hands and using the side of the fingertip both help. Timing matters more than technique: avoid collecting within two to four weeks of an illness, a vaccination, an unusually hard training block, or a badly disrupted sleep stretch, because each shifts inflammatory markers or blood cell proportions.
Can I compare a TruDiagnostic result to one from another company?
No. Different providers use different platforms, normalization pipelines, marker sets and reference populations, and two labs can process the same sample and return numbers differing by several years without either being wrong. That makes cross-vendor tracking invalid. If you intend to follow a trend over years, pick one provider and stay with it — switching resets your baseline, and the apparent jump will be a methodology artifact rather than a change in you. The same caution applies to comparing a result against a figure quoted by a friend or in a podcast.
Who should buy something else?
Anyone who has never run a comprehensive blood panel, because fasting insulin, HbA1c, ApoB, hs-CRP and blood pressure cost less and name specific, treatable problems. Anyone who wants one simple number and no technical detail, since the depth of this report is a genuine usability cost. Anyone unwilling to do a finger-prick collection. And anyone testing once out of curiosity, because every output here — the age figures, the pace measure, the cell proportions — is far more informative as a trend than as a single point.